title: Effects of the phytoestrogen genistein on the porcine anterior pituitary insulin-like growth factor system.
abstract: Estrogens have profound effects on the serum and anterior pituitary (AP) insulin-like growth factor (IGF) system in pigs. In this study we determined whether administration of the phytoestrogen genistein increased serum and AP concentrations of IGF-I and relative amounts of serum and AP insulin-like growth factor-binding protein (IGFBP). Twenty barrows of similar age (190 d) and weight (110 kg) were stratified by litter into one of four treatments: controls (C), estradiol (E), 200 mg genistein (G200), and 400 mg genistein (G400). Estradiol-treated pigs were injected daily with 2 mg of estradiol-17β intramuscularly (i.m.), whereas the G200 and G400 groups were injected daily with either 200 or 400 mg of genistein i.m., respectively, beginning on d 0 and continuing through d 15. Blood was collected on d 0, 3, 6, 9, and 13. Blood and AP were collected at slaughter on d 16. Serum and AP concentrations of IGF-I and luteinizing hormone (LH) were determined by radioimmunoassay. Relative amounts of serum IGFBP were determined by Western ligand blot analysis. Relative expression of AP IGF-I, IGF-I receptor (IGF-IR), gonadotropin-releasing hormone receptor, and LHβ subunit was determined by real-time reverse transcriptase polymerase chain reaction. Anterior pituitary concentrations of IGF-I were greater (P > 0.05) in E and G400 pigs compared with controls, whereas AP concentrations of LH were greater (P < 0.05) in G400 pigs compared with C and G200 pigs. Relative expression of LHβ was greater in G200 pigs compared with C pigs but did not differ from that in G400 pigs. Relative expression of AP IGF-IR was greater (P < 0.05) in E pigs compared with all other treatments; however, relative expression of AP IGF-IR was greater (P < 0.05) in both G200 and G400 pigs vs C pigs. No differences were detected (P > 0.05) in serum concentrations of IGF-I or relative amounts of serum and AP IGFBP among treatments. These data provide evidence that genistein is capable of modulating components of the AP IGF system that could affect the synthesis and release of LH.
authors.affiliation: Department of Animal and Range Sciences, South Dakota State University, Brookings, SD 57007, USA. jeffrey.clapper@sdstate.edu
authors.forename: J
authors.initials: J
authors.lastname: Clapper
authors.forename: A
authors.initials: A
authors.lastname: Tomlin
mesh_terms: D000818:Animals; D004958:Estradiol / Q000494:pharmacology*; D019833:Genistein / Q000494:pharmacology*; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood; D037101:Luteinizing Hormone, beta Subunit / Q000096:biosynthesis; D008297:Male; D048789:Phytoestrogens / Q000494:pharmacology*; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D017526:Receptor, IGF Type 1 / Q000096:biosynthesis; D011966:Receptors, LHRH / Q000096:biosynthesis; D013552:Swine / Q000378:metabolism*
chemical_list: D018969:Insulin-Like Growth Factor Binding Proteins; D037101:Luteinizing Hormone, beta Subunit; D048789:Phytoestrogens; D011966:Receptors, LHRH; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D007986:Luteinizing Hormone; D019833:Genistein; D017526:Receptor, IGF Type 1